

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 5.29822210 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.29822210 |
| 3 | NADH metabolic process (GO:0006734) | 4.63801166 |
| 4 | regulation of early endosome to late endosome transport (GO:2000641) | 4.56573870 |
| 5 | folic acid transport (GO:0015884) | 4.55980809 |
| 6 | GDP-mannose metabolic process (GO:0019673) | 4.44687817 |
| 7 | regulation of translational termination (GO:0006449) | 4.44404729 |
| 8 | folic acid metabolic process (GO:0046655) | 4.34887833 |
| 9 | purine nucleobase biosynthetic process (GO:0009113) | 4.25230810 |
| 10 | galactose catabolic process (GO:0019388) | 4.01566949 |
| 11 | proteasome assembly (GO:0043248) | 3.94004176 |
| 12 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.86194507 |
| 13 | GMP metabolic process (GO:0046037) | 3.76454701 |
| 14 | L-methionine salvage (GO:0071267) | 3.74483052 |
| 15 | L-methionine biosynthetic process (GO:0071265) | 3.74483052 |
| 16 | amino acid salvage (GO:0043102) | 3.74483052 |
| 17 | formation of translation preinitiation complex (GO:0001731) | 3.73498702 |
| 18 | autophagic vacuole assembly (GO:0000045) | 3.66529332 |
| 19 | nucleobase biosynthetic process (GO:0046112) | 3.59240272 |
| 20 | protein maturation by protein folding (GO:0022417) | 3.56536237 |
| 21 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.55401112 |
| 22 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.52645746 |
| 23 | neuromuscular process controlling posture (GO:0050884) | 3.52039927 |
| 24 | modified amino acid transport (GO:0072337) | 3.51491751 |
| 25 | protein localization to endosome (GO:0036010) | 3.50149275 |
| 26 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.49428648 |
| 27 | ribosome assembly (GO:0042255) | 3.46219876 |
| 28 | protein retention in ER lumen (GO:0006621) | 3.35679306 |
| 29 | sodium ion export (GO:0071436) | 3.34699006 |
| 30 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.33722428 |
| 31 | vitamin transmembrane transport (GO:0035461) | 3.32881810 |
| 32 | DNA deamination (GO:0045006) | 3.28283733 |
| 33 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.25811707 |
| 34 | stress fiber assembly (GO:0043149) | 3.25687759 |
| 35 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.25592209 |
| 36 | barbed-end actin filament capping (GO:0051016) | 3.24525594 |
| 37 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.22380386 |
| 38 | negative regulation of ligase activity (GO:0051352) | 3.21805830 |
| 39 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.21805830 |
| 40 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.20484899 |
| 41 | negative regulation of microtubule polymerization (GO:0031115) | 3.18591871 |
| 42 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.17105330 |
| 43 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.16092318 |
| 44 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.15378950 |
| 45 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.11385295 |
| 46 | * CDP-diacylglycerol metabolic process (GO:0046341) | 3.09993717 |
| 47 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.09993717 |
| 48 | synaptic vesicle maturation (GO:0016188) | 3.08738162 |
| 49 | positive regulation of synapse maturation (GO:0090129) | 3.08173630 |
| 50 | positive regulation of ligase activity (GO:0051351) | 2.99340794 |
| 51 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.98349842 |
| 52 | synaptic vesicle exocytosis (GO:0016079) | 2.97564760 |
| 53 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.96077229 |
| 54 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.94376590 |
| 55 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.93866312 |
| 56 | basement membrane organization (GO:0071711) | 2.92452796 |
| 57 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.92068843 |
| 58 | regulation of translation in response to stress (GO:0043555) | 2.91403222 |
| 59 | lung-associated mesenchyme development (GO:0060484) | 2.89250461 |
| 60 | cellular metabolic compound salvage (GO:0043094) | 2.88403045 |
| 61 | purine nucleotide salvage (GO:0032261) | 2.88350330 |
| 62 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.86746033 |
| 63 | negative regulation of cell size (GO:0045792) | 2.83964821 |
| 64 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.83336156 |
| 65 | regulation of defense response to virus by virus (GO:0050690) | 2.82420439 |
| 66 | apoptotic process involved in morphogenesis (GO:0060561) | 2.80116562 |
| 67 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.78481603 |
| 68 | labyrinthine layer development (GO:0060711) | 2.77404047 |
| 69 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.77287307 |
| 70 | cellular potassium ion homeostasis (GO:0030007) | 2.77122288 |
| 71 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.76380287 |
| 72 | positive regulation of receptor recycling (GO:0001921) | 2.75968722 |
| 73 | cell-cell junction maintenance (GO:0045217) | 2.75441585 |
| 74 | methionine biosynthetic process (GO:0009086) | 2.69559287 |
| 75 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.68846579 |
| 76 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.68694621 |
| 77 | adhesion of symbiont to host cell (GO:0044650) | 2.67943864 |
| 78 | virion attachment to host cell (GO:0019062) | 2.67943864 |
| 79 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.67589615 |
| 80 | pantothenate metabolic process (GO:0015939) | 2.66843923 |
| 81 | adhesion of symbiont to host (GO:0044406) | 2.65601136 |
| 82 | methionine metabolic process (GO:0006555) | 2.65351793 |
| 83 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.65165263 |
| 84 | positive regulation of nuclease activity (GO:0032075) | 2.64107239 |
| 85 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.63173228 |
| 86 | glutamate secretion (GO:0014047) | 2.61837098 |
| 87 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.61413792 |
| 88 | protein targeting to plasma membrane (GO:0072661) | 2.60302911 |
| 89 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.60192302 |
| 90 | mannose metabolic process (GO:0006013) | 2.60005917 |
| 91 | tooth mineralization (GO:0034505) | 2.59644060 |
| 92 | modulation by symbiont of host cellular process (GO:0044068) | 2.59229893 |
| 93 | localization within membrane (GO:0051668) | 2.58865987 |
| 94 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.58782555 |
| 95 | regulation of extracellular matrix disassembly (GO:0010715) | 2.58510085 |
| 96 | adherens junction assembly (GO:0034333) | 2.58058577 |
| 97 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.56674045 |
| 98 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.56082271 |
| 99 | regulation of ligase activity (GO:0051340) | 2.56039838 |
| 100 | intestinal epithelial cell development (GO:0060576) | 2.55915280 |
| 101 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.54753634 |
| 102 | regulation of cellular amine metabolic process (GO:0033238) | 2.54690540 |
| 103 | ribosome biogenesis (GO:0042254) | 2.54490671 |
| 104 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.54294238 |
| 105 | transferrin transport (GO:0033572) | 2.53608375 |
| 106 | protein insertion into membrane (GO:0051205) | 2.53305889 |
| 107 | regulation of leukocyte degranulation (GO:0043300) | 2.51937244 |
| 108 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.50774606 |
| 109 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.50562650 |
| 110 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.50562650 |
| 111 | establishment of protein localization to mitochondrion (GO:0072655) | 2.50256680 |
| 112 | modulation by virus of host process (GO:0019054) | 2.49881409 |
| 113 | regulation of synaptic vesicle transport (GO:1902803) | 2.49606849 |
| 114 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.49396144 |
| 115 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.49396144 |
| 116 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.49396144 |
| 117 | focal adhesion assembly (GO:0048041) | 2.49145988 |
| 118 | cell-substrate adherens junction assembly (GO:0007045) | 2.49145988 |
| 119 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.48471887 |
| 120 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.48471887 |
| 121 | regulation of ARF protein signal transduction (GO:0032012) | 2.47958984 |
| 122 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.47694677 |
| 123 | positive regulation of autophagy (GO:0010508) | 2.45740550 |
| 124 | vitamin transport (GO:0051180) | 2.45586967 |
| 125 | ribonucleoprotein complex disassembly (GO:0032988) | 2.45564563 |
| 126 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.45474808 |
| 127 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.45474808 |
| 128 | receptor recycling (GO:0001881) | 2.45409005 |
| 129 | interferon-gamma secretion (GO:0072643) | 2.45399946 |
| 130 | antigen processing and presentation of exogenous peptide antigen (GO:0002478) | 2.45385302 |
| 131 | peptidyl-proline hydroxylation (GO:0019511) | 2.45377294 |
| 132 | pinocytosis (GO:0006907) | 2.45341040 |
| 133 | vesicle coating (GO:0006901) | 2.45186577 |
| 134 | negative regulation of cell killing (GO:0031342) | 2.44598862 |
| 135 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.44598862 |
| 136 | regulation of regulated secretory pathway (GO:1903305) | 2.44367894 |
| 137 | semaphorin-plexin signaling pathway (GO:0071526) | 2.42833358 |
| 138 | maternal placenta development (GO:0001893) | 2.41424669 |
| 139 | positive regulation of protein dephosphorylation (GO:0035307) | 2.38904717 |
| 140 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.37507472 |
| 141 | negative regulation of fatty acid transport (GO:2000192) | 2.37206841 |
| 142 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.35854653 |
| 143 | embryo implantation (GO:0007566) | 2.33152043 |
| 144 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.32338184 |
| 145 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.32338184 |
| 146 | cerebellar granule cell differentiation (GO:0021707) | 2.32241420 |
| 147 | modulation by virus of host morphology or physiology (GO:0019048) | 2.31258756 |
| 148 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.30760634 |
| 149 | ribosomal small subunit biogenesis (GO:0042274) | 2.30327736 |
| 150 | dopamine receptor signaling pathway (GO:0007212) | 2.29391812 |
| 151 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.25853577 |
| 152 | activation of MAPKKK activity (GO:0000185) | 2.25710747 |
| 153 | response to laminar fluid shear stress (GO:0034616) | 2.25348757 |
| 154 | cell-substrate junction assembly (GO:0007044) | 2.24978201 |
| 155 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.24738058 |
| 156 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.23373889 |
| 157 | pentose-phosphate shunt (GO:0006098) | 2.22351027 |
| 158 | positive regulation by symbiont of host defense response (GO:0052509) | 2.22204365 |
| 159 | modulation by symbiont of host defense response (GO:0052031) | 2.22204365 |
| 160 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.22204365 |
| 161 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.22204365 |
| 162 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.22204365 |
| 163 | modulation by symbiont of host immune response (GO:0052553) | 2.22204365 |
| 164 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.21209044 |
| 165 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.18950041 |
| 166 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.18792779 |
| 167 | hyaluronan catabolic process (GO:0030214) | 2.18393350 |
| 168 | protein carboxylation (GO:0018214) | 2.17822628 |
| 169 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.17822628 |
| 170 | response to acidic pH (GO:0010447) | 2.16879095 |
| 171 | glucose 6-phosphate metabolic process (GO:0051156) | 2.15500914 |
| 172 | regulation of mast cell degranulation (GO:0043304) | 2.15086579 |
| 173 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.15030616 |
| 174 | regulation of ARF GTPase activity (GO:0032312) | 2.13875967 |
| 175 | regulation of necrotic cell death (GO:0010939) | 2.13425389 |
| 176 | skin morphogenesis (GO:0043589) | 2.11629229 |
| 177 | response to parathyroid hormone (GO:0071107) | 2.11367120 |
| 178 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.11061387 |
| 179 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.10185823 |
| 180 | UV protection (GO:0009650) | 2.09274727 |
| 181 | virion assembly (GO:0019068) | 2.08925816 |
| 182 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.08392163 |
| 183 | positive regulation of regulated secretory pathway (GO:1903307) | 2.07404189 |
| 184 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.07270333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.70839261 |
| 2 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.92962325 |
| 3 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.92558536 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.87818251 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.84753156 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.49249157 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.48444236 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.28924740 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.28458512 |
| 10 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08610572 |
| 11 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.04970542 |
| 12 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.04389310 |
| 13 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.02922172 |
| 14 | KDM2B_26808549_Chip-Seq_K562_Human | 2.02504422 |
| 15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.01314781 |
| 16 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.97746439 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95753601 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.89108362 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.87313036 |
| 20 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.85745395 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 1.84232994 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.83810641 |
| 23 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.82818539 |
| 24 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.81281773 |
| 25 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.77413714 |
| 26 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.75819182 |
| 27 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.74598894 |
| 28 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.73127395 |
| 29 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.67822320 |
| 30 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.65297984 |
| 31 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.63385996 |
| 32 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.63245515 |
| 33 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.62049518 |
| 34 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.60833300 |
| 35 | ATF3_27146783_Chip-Seq_COLON_Human | 1.60085777 |
| 36 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.59628374 |
| 37 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.58638808 |
| 38 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.57589393 |
| 39 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.57100064 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50748965 |
| 41 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.49107762 |
| 42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.46989018 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46722000 |
| 44 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.46153031 |
| 45 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.45851143 |
| 46 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.45359871 |
| 47 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.45204472 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.44009510 |
| 49 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.43899391 |
| 50 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43126494 |
| 51 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.42716833 |
| 52 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.42553583 |
| 53 | P68_20966046_ChIP-Seq_HELA_Human | 1.41511365 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41250715 |
| 55 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.40957179 |
| 56 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39848608 |
| 57 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.39753136 |
| 58 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.37591633 |
| 59 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35974674 |
| 60 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.35032440 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35001885 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34898626 |
| 63 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.34794217 |
| 64 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.34526990 |
| 65 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.33335682 |
| 66 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.31917338 |
| 67 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.31733792 |
| 68 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.30922902 |
| 69 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30308905 |
| 70 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.29149605 |
| 71 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.28885478 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27542791 |
| 73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.26364455 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26109471 |
| 75 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.25435694 |
| 76 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.24755119 |
| 77 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.24282381 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23917212 |
| 79 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23386965 |
| 80 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22970591 |
| 81 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.22742356 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22169369 |
| 83 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21696834 |
| 84 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.21506191 |
| 85 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20693851 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20280732 |
| 87 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20045073 |
| 88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19517830 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19405753 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19389395 |
| 91 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.19342231 |
| 92 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.19139202 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18836274 |
| 94 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.18395034 |
| 95 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18325710 |
| 96 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18119078 |
| 97 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.18117703 |
| 98 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17952034 |
| 99 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16520712 |
| 100 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16460383 |
| 101 | MAF_26560356_Chip-Seq_TH2_Human | 1.16429744 |
| 102 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.15771182 |
| 103 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15110774 |
| 104 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.15023431 |
| 105 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14818831 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14343418 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14154910 |
| 108 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14026535 |
| 109 | MAF_26560356_Chip-Seq_TH1_Human | 1.13956517 |
| 110 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13854120 |
| 111 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.12954854 |
| 112 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12442467 |
| 113 | SA1_27219007_Chip-Seq_Bcells_Human | 1.12262357 |
| 114 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12208524 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11468914 |
| 116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10649334 |
| 117 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.10475374 |
| 118 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10337509 |
| 119 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.10199717 |
| 120 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.10067427 |
| 121 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09586331 |
| 122 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.09524192 |
| 123 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09254358 |
| 124 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.08975859 |
| 125 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.08718970 |
| 126 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08459230 |
| 127 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.08212797 |
| 128 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.07760948 |
| 129 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07068257 |
| 130 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06978860 |
| 131 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.06247892 |
| 132 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06200038 |
| 133 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.05869547 |
| 134 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.05451655 |
| 135 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04925824 |
| 136 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.04885792 |
| 137 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04786452 |
| 138 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.04739665 |
| 139 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.04310771 |
| 140 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.04261517 |
| 141 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04167984 |
| 142 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.03708328 |
| 143 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03327123 |
| 144 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02903886 |
| 145 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.02859405 |
| 146 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02576256 |
| 147 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02469150 |
| 148 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.00098399 |
| 149 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99141874 |
| 150 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98093018 |
| 151 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.97953118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 5.50509743 |
| 2 | MP0003329_amyloid_beta_deposits | 3.91196236 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.72341401 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.39132127 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.36155539 |
| 6 | MP0003693_abnormal_embryo_hatching | 3.20578426 |
| 7 | MP0008260_abnormal_autophagy | 3.00984781 |
| 8 | MP0004858_abnormal_nervous_system | 2.67964621 |
| 9 | MP0000013_abnormal_adipose_tissue | 2.55603488 |
| 10 | MP0005451_abnormal_body_composition | 2.40217430 |
| 11 | MP0000604_amyloidosis | 2.40178729 |
| 12 | MP0004270_analgesia | 2.36132496 |
| 13 | MP0004510_myositis | 2.30624138 |
| 14 | MP0002909_abnormal_adrenal_gland | 2.20422009 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.18918984 |
| 16 | MP0001849_ear_inflammation | 2.15309445 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.12659948 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.03484301 |
| 19 | MP0003436_decreased_susceptibility_to | 2.00485547 |
| 20 | MP0003879_abnormal_hair_cell | 1.94630457 |
| 21 | MP0009278_abnormal_bone_marrow | 1.85683299 |
| 22 | MP0009379_abnormal_foot_pigmentation | 1.85124436 |
| 23 | MP0000747_muscle_weakness | 1.84317721 |
| 24 | MP0002736_abnormal_nociception_after | 1.83342335 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.82725806 |
| 26 | MP0004957_abnormal_blastocyst_morpholog | 1.75960413 |
| 27 | MP0005503_abnormal_tendon_morphology | 1.74350272 |
| 28 | MP0000678_abnormal_parathyroid_gland | 1.71455743 |
| 29 | MP0001756_abnormal_urination | 1.69277549 |
| 30 | MP0002734_abnormal_mechanical_nocicepti | 1.68133447 |
| 31 | MP0000358_abnormal_cell_content/ | 1.67811796 |
| 32 | MP0003635_abnormal_synaptic_transmissio | 1.66130574 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.65536718 |
| 34 | MP0001970_abnormal_pain_threshold | 1.60535420 |
| 35 | MP0001348_abnormal_lacrimal_gland | 1.60379917 |
| 36 | MP0004185_abnormal_adipocyte_glucose | 1.53422028 |
| 37 | MP0003866_abnormal_defecation | 1.52388736 |
| 38 | MP0005409_darkened_coat_color | 1.51364260 |
| 39 | MP0005275_abnormal_skin_tensile | 1.49396420 |
| 40 | MP0005257_abnormal_intraocular_pressure | 1.48038684 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.45695257 |
| 42 | MP0002796_impaired_skin_barrier | 1.43334611 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.41405328 |
| 44 | MP0001542_abnormal_bone_strength | 1.41359924 |
| 45 | MP0000858_altered_metastatic_potential | 1.39535331 |
| 46 | MP0003718_maternal_effect | 1.37168537 |
| 47 | MP0005083_abnormal_biliary_tract | 1.34334977 |
| 48 | MP0002064_seizures | 1.31325727 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.30079020 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.29351457 |
| 51 | MP0010234_abnormal_vibrissa_follicle | 1.29076736 |
| 52 | MP0005423_abnormal_somatic_nervous | 1.27687291 |
| 53 | MP0005332_abnormal_amino_acid | 1.24978633 |
| 54 | MP0000751_myopathy | 1.24509114 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.24093521 |
| 56 | MP0002249_abnormal_larynx_morphology | 1.23675046 |
| 57 | MP0004272_abnormal_basement_membrane | 1.22371811 |
| 58 | MP0003091_abnormal_cell_migration | 1.21996620 |
| 59 | MP0004084_abnormal_cardiac_muscle | 1.21758556 |
| 60 | MP0001730_embryonic_growth_arrest | 1.21273193 |
| 61 | MP0003724_increased_susceptibility_to | 1.20773216 |
| 62 | MP0008004_abnormal_stomach_pH | 1.20451014 |
| 63 | MP0000681_abnormal_thyroid_gland | 1.20387490 |
| 64 | MP0005375_adipose_tissue_phenotype | 1.19778669 |
| 65 | MP0009384_cardiac_valve_regurgitation | 1.19674725 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.17819573 |
| 67 | MP0003303_peritoneal_inflammation | 1.16996616 |
| 68 | MP0003453_abnormal_keratinocyte_physiol | 1.16408779 |
| 69 | MP0008874_decreased_physiological_sensi | 1.14127978 |
| 70 | MP0000003_abnormal_adipose_tissue | 1.12404991 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 1.12226151 |
| 72 | MP0002269_muscular_atrophy | 1.11520769 |
| 73 | MP0010368_abnormal_lymphatic_system | 1.11266033 |
| 74 | MP0005623_abnormal_meninges_morphology | 1.10084989 |
| 75 | MP0005390_skeleton_phenotype | 1.08829082 |
| 76 | MP0002419_abnormal_innate_immunity | 1.08510653 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 1.06933254 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 1.04662188 |
| 79 | MP0001958_emphysema | 1.03368774 |
| 80 | MP0000767_abnormal_smooth_muscle | 1.02388946 |
| 81 | MP0005508_abnormal_skeleton_morphology | 1.00526258 |
| 82 | MP0002653_abnormal_ependyma_morphology | 1.00124796 |
| 83 | MP0003705_abnormal_hypodermis_morpholog | 0.99736561 |
| 84 | MP0001440_abnormal_grooming_behavior | 0.99634160 |
| 85 | MP0005076_abnormal_cell_differentiation | 0.99239700 |
| 86 | MP0003221_abnormal_cardiomyocyte_apopto | 0.99033944 |
| 87 | MP0002060_abnormal_skin_morphology | 0.98583097 |
| 88 | MP0005501_abnormal_skin_physiology | 0.98292890 |
| 89 | MP0005025_abnormal_response_to | 0.97040048 |
| 90 | MP0010352_gastrointestinal_tract_polyps | 0.96717458 |
| 91 | MP0004811_abnormal_neuron_physiology | 0.96656690 |
| 92 | MP0003123_paternal_imprinting | 0.96553421 |
| 93 | MP0000343_altered_response_to | 0.95536730 |
| 94 | MP0006035_abnormal_mitochondrial_morpho | 0.95235669 |
| 95 | MP0001666_abnormal_nutrient_absorption | 0.95215770 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 0.94303451 |
| 97 | MP0002089_abnormal_postnatal_growth/wei | 0.93726793 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.93284893 |
| 99 | MP0002063_abnormal_learning/memory/cond | 0.93272372 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.92972666 |
| 101 | MP0000462_abnormal_digestive_system | 0.92705144 |
| 102 | MP0001501_abnormal_sleep_pattern | 0.91897199 |
| 103 | MP0003111_abnormal_nucleus_morphology | 0.89022645 |
| 104 | MP0000920_abnormal_myelination | 0.87550073 |
| 105 | MP0000750_abnormal_muscle_regeneration | 0.86667363 |
| 106 | MP0001986_abnormal_taste_sensitivity | 0.86488698 |
| 107 | MP0003690_abnormal_glial_cell | 0.85473467 |
| 108 | MP0004043_abnormal_pH_regulation | 0.84474415 |
| 109 | MP0005166_decreased_susceptibility_to | 0.84433641 |
| 110 | MP0003566_abnormal_cell_adhesion | 0.82704409 |
| 111 | MP0005670_abnormal_white_adipose | 0.81239095 |
| 112 | MP0009745_abnormal_behavioral_response | 0.81192188 |
| 113 | MP0003828_pulmonary_edema | 0.80056090 |
| 114 | MP0005330_cardiomyopathy | 0.79720712 |
| 115 | MP0005310_abnormal_salivary_gland | 0.79315545 |
| 116 | MP0000465_gastrointestinal_hemorrhage | 0.79150725 |
| 117 | MP0004130_abnormal_muscle_cell | 0.78268184 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.77781051 |
| 119 | MP0003283_abnormal_digestive_organ | 0.77756907 |
| 120 | MP0005636_abnormal_mineral_homeostasis | 0.76403180 |
| 121 | MP0005621_abnormal_cell_physiology | 0.75700298 |
| 122 | MP0003634_abnormal_glial_cell | 0.75644283 |
| 123 | MP0000685_abnormal_immune_system | 0.75277535 |
| 124 | MP0002080_prenatal_lethality | 0.75131720 |
| 125 | MP0001944_abnormal_pancreas_morphology | 0.75032994 |
| 126 | MP0002272_abnormal_nervous_system | 0.74996981 |
| 127 | MP0009046_muscle_twitch | 0.74756593 |
| 128 | MP0004381_abnormal_hair_follicle | 0.74148126 |
| 129 | MP0008569_lethality_at_weaning | 0.73448401 |
| 130 | MP0005671_abnormal_response_to | 0.73312884 |
| 131 | MP0001661_extended_life_span | 0.72730946 |
| 132 | MP0002132_abnormal_respiratory_system | 0.72709522 |
| 133 | MP0005360_urolithiasis | 0.72204380 |
| 134 | MP0002933_joint_inflammation | 0.71689651 |
| 135 | MP0005464_abnormal_platelet_physiology | 0.70725958 |
| 136 | MP0006082_CNS_inflammation | 0.70261266 |
| 137 | MP0003806_abnormal_nucleotide_metabolis | 0.69991461 |
| 138 | MP0002295_abnormal_pulmonary_circulatio | 0.69903636 |
| 139 | MP0005384_cellular_phenotype | 0.69529553 |
| 140 | MP0008961_abnormal_basal_metabolism | 0.69407956 |
| 141 | MP0005000_abnormal_immune_tolerance | 0.68536387 |
| 142 | MP0004019_abnormal_vitamin_homeostasis | 0.68446691 |
| 143 | MP0003638_abnormal_response/metabolism_ | 0.68180243 |
| 144 | MP0001905_abnormal_dopamine_level | 0.66944841 |
| 145 | MP0003183_abnormal_peptide_metabolism | 0.66673814 |
| 146 | MP0002896_abnormal_bone_mineralization | 0.65768910 |
| 147 | MP0003878_abnormal_ear_physiology | 0.65514614 |
| 148 | MP0005377_hearing/vestibular/ear_phenot | 0.65514614 |
| 149 | MP0003075_altered_response_to | 0.65286464 |
| 150 | MP0005023_abnormal_wound_healing | 0.65151226 |
| 151 | MP0003795_abnormal_bone_structure | 0.64779646 |
| 152 | MP0003448_altered_tumor_morphology | 0.64701320 |
| 153 | MP0004947_skin_inflammation | 0.64033471 |
| 154 | MP0010155_abnormal_intestine_physiology | 0.63763637 |
| 155 | MP0001851_eye_inflammation | 0.63322900 |
| 156 | MP0009780_abnormal_chondrocyte_physiolo | 0.63304422 |
| 157 | MP0000534_abnormal_ureter_morphology | 0.63303581 |
| 158 | MP0005319_abnormal_enzyme/_coenzyme | 0.62907137 |
| 159 | MP0000490_abnormal_crypts_of | 0.62446371 |
| 160 | MP0005395_other_phenotype | 0.62260062 |
| 161 | MP0005165_increased_susceptibility_to | 0.62218711 |
| 162 | MP0000759_abnormal_skeletal_muscle | 0.61915354 |
| 163 | MP0009931_abnormal_skin_appearance | 0.61579093 |
| 164 | MP0003279_aneurysm | 0.61367438 |
| 165 | MP0005595_abnormal_vascular_smooth | 0.61233815 |
| 166 | MP0004233_abnormal_muscle_weight | 0.60959326 |
| 167 | MP0002837_dystrophic_cardiac_calcinosis | 0.60445539 |
| 168 | MP0002136_abnormal_kidney_physiology | 0.59382073 |
| 169 | MP0002067_abnormal_sensory_capabilities | 0.58937515 |
| 170 | MP0004036_abnormal_muscle_relaxation | 0.58418921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.16640559 |
| 2 | Gout (HP:0001997) | 3.83423988 |
| 3 | Cerebral hypomyelination (HP:0006808) | 3.69622804 |
| 4 | Visual hallucinations (HP:0002367) | 3.37815958 |
| 5 | Delusions (HP:0000746) | 3.36789776 |
| 6 | Dysautonomia (HP:0002459) | 3.30026981 |
| 7 | Ventricular fibrillation (HP:0001663) | 3.20915056 |
| 8 | Bundle branch block (HP:0011710) | 3.14004041 |
| 9 | Progressive muscle weakness (HP:0003323) | 3.02690957 |
| 10 | Microretrognathia (HP:0000308) | 2.94269178 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 2.94055975 |
| 12 | Myokymia (HP:0002411) | 2.91155667 |
| 13 | Difficulty climbing stairs (HP:0003551) | 2.89373813 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.87642687 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.87642687 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 2.87642687 |
| 17 | Obstructive sleep apnea (HP:0002870) | 2.79212499 |
| 18 | Increased variability in muscle fiber diameter (HP:0003557) | 2.74584109 |
| 19 | Polycythemia (HP:0001901) | 2.73510124 |
| 20 | Dysostosis multiplex (HP:0000943) | 2.71695710 |
| 21 | Myopathic facies (HP:0002058) | 2.68319947 |
| 22 | Postnatal microcephaly (HP:0005484) | 2.65559793 |
| 23 | Athetosis (HP:0002305) | 2.64981922 |
| 24 | Global brain atrophy (HP:0002283) | 2.64009939 |
| 25 | Eczematoid dermatitis (HP:0000976) | 2.63321507 |
| 26 | Mutism (HP:0002300) | 2.57062526 |
| 27 | Cerebral inclusion bodies (HP:0100314) | 2.55693523 |
| 28 | Premature rupture of membranes (HP:0001788) | 2.54070252 |
| 29 | Neurofibrillary tangles (HP:0002185) | 2.52942620 |
| 30 | Ankle contracture (HP:0006466) | 2.51511463 |
| 31 | Abnormality of the umbilical cord (HP:0010881) | 2.50534156 |
| 32 | CNS hypomyelination (HP:0003429) | 2.49645379 |
| 33 | Tetraplegia (HP:0002445) | 2.49578383 |
| 34 | Death in infancy (HP:0001522) | 2.49330433 |
| 35 | Personality changes (HP:0000751) | 2.47998100 |
| 36 | Hand muscle atrophy (HP:0009130) | 2.47992575 |
| 37 | Cervical subluxation (HP:0003308) | 2.44857407 |
| 38 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.44396198 |
| 39 | Short nail (HP:0001799) | 2.39144957 |
| 40 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.39132078 |
| 41 | Systemic lupus erythematosus (HP:0002725) | 2.36060297 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.34601155 |
| 43 | Emotional lability (HP:0000712) | 2.33655325 |
| 44 | Multiple enchondromatosis (HP:0005701) | 2.32376123 |
| 45 | Ankle clonus (HP:0011448) | 2.30325550 |
| 46 | Fragile skin (HP:0001030) | 2.28792372 |
| 47 | Diminished motivation (HP:0000745) | 2.28740039 |
| 48 | Increased connective tissue (HP:0009025) | 2.27892076 |
| 49 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.27411605 |
| 50 | Distal upper limb amyotrophy (HP:0007149) | 2.26976539 |
| 51 | Upper limb amyotrophy (HP:0009129) | 2.26976539 |
| 52 | Peritonitis (HP:0002586) | 2.26094068 |
| 53 | Atrioventricular block (HP:0001678) | 2.25299995 |
| 54 | Restlessness (HP:0000711) | 2.25027502 |
| 55 | Supranuclear gaze palsy (HP:0000605) | 2.24607321 |
| 56 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.24309584 |
| 57 | Abnormality of alanine metabolism (HP:0010916) | 2.24309584 |
| 58 | Hyperalaninemia (HP:0003348) | 2.24309584 |
| 59 | Blue sclerae (HP:0000592) | 2.23358772 |
| 60 | Abnormal neuron morphology (HP:0012757) | 2.21932805 |
| 61 | Abnormality of the motor neurons (HP:0002450) | 2.21932805 |
| 62 | Rough bone trabeculation (HP:0100670) | 2.20632621 |
| 63 | Apathy (HP:0000741) | 2.20325877 |
| 64 | Distal lower limb muscle weakness (HP:0009053) | 2.19485860 |
| 65 | Unsteady gait (HP:0002317) | 2.18319877 |
| 66 | Hyperacusis (HP:0010780) | 2.17549086 |
| 67 | Thin bony cortex (HP:0002753) | 2.17479004 |
| 68 | Vacuolated lymphocytes (HP:0001922) | 2.17101997 |
| 69 | Degeneration of anterior horn cells (HP:0002398) | 2.16833131 |
| 70 | Abnormality of the anterior horn cell (HP:0006802) | 2.16833131 |
| 71 | Breast hypoplasia (HP:0003187) | 2.16830831 |
| 72 | Genu recurvatum (HP:0002816) | 2.16384936 |
| 73 | Patent foramen ovale (HP:0001655) | 2.15446908 |
| 74 | Purpura (HP:0000979) | 2.14964873 |
| 75 | Cellulitis (HP:0100658) | 2.14909285 |
| 76 | Hyperglycinemia (HP:0002154) | 2.14350844 |
| 77 | Pustule (HP:0200039) | 2.13484812 |
| 78 | Abnormality of macrophages (HP:0004311) | 2.13240177 |
| 79 | Joint stiffness (HP:0001387) | 2.13005477 |
| 80 | Amyotrophic lateral sclerosis (HP:0007354) | 2.12764013 |
| 81 | Axonal loss (HP:0003447) | 2.12674233 |
| 82 | J-shaped sella turcica (HP:0002680) | 2.11845950 |
| 83 | Mitral regurgitation (HP:0001653) | 2.11022146 |
| 84 | Neuroendocrine neoplasm (HP:0100634) | 2.10360562 |
| 85 | Ulnar bowing (HP:0003031) | 2.09911507 |
| 86 | Generalized amyotrophy (HP:0003700) | 2.07841220 |
| 87 | Deep venous thrombosis (HP:0002625) | 2.07652028 |
| 88 | Pheochromocytoma (HP:0002666) | 2.07623509 |
| 89 | Shallow orbits (HP:0000586) | 2.07195114 |
| 90 | Interstitial pulmonary disease (HP:0006530) | 2.06259047 |
| 91 | Impaired pain sensation (HP:0007328) | 2.06211164 |
| 92 | Abnormality of pain sensation (HP:0010832) | 2.06211164 |
| 93 | Broad metatarsal (HP:0001783) | 2.04320229 |
| 94 | Dilatation of the ascending aorta (HP:0005111) | 2.03150522 |
| 95 | Glucose intolerance (HP:0000833) | 2.02583071 |
| 96 | CNS demyelination (HP:0007305) | 2.02375432 |
| 97 | Disproportionate tall stature (HP:0001519) | 2.01939241 |
| 98 | Spinal rigidity (HP:0003306) | 2.01150494 |
| 99 | Ileus (HP:0002595) | 2.01118794 |
| 100 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.99945606 |
| 101 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.99706058 |
| 102 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.99706058 |
| 103 | Megaloblastic anemia (HP:0001889) | 1.99655141 |
| 104 | Mucopolysacchariduria (HP:0008155) | 1.99317003 |
| 105 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99317003 |
| 106 | Emphysema (HP:0002097) | 1.98893144 |
| 107 | Carpal bone hypoplasia (HP:0001498) | 1.98519850 |
| 108 | Hemorrhage of the eye (HP:0011885) | 1.97358334 |
| 109 | Distal lower limb amyotrophy (HP:0008944) | 1.96878589 |
| 110 | Aortic aneurysm (HP:0004942) | 1.96578345 |
| 111 | Spastic paraparesis (HP:0002313) | 1.95804013 |
| 112 | Vascular tortuosity (HP:0004948) | 1.94269573 |
| 113 | Asymmetric septal hypertrophy (HP:0001670) | 1.93815843 |
| 114 | Long palpebral fissure (HP:0000637) | 1.93813315 |
| 115 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.93709132 |
| 116 | Bladder diverticulum (HP:0000015) | 1.93366165 |
| 117 | Rapidly progressive (HP:0003678) | 1.93025701 |
| 118 | Gastrointestinal dysmotility (HP:0002579) | 1.92195544 |
| 119 | Wormian bones (HP:0002645) | 1.91430502 |
| 120 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90698693 |
| 121 | Achilles tendon contracture (HP:0001771) | 1.89819403 |
| 122 | Hypercortisolism (HP:0001578) | 1.88806728 |
| 123 | Turricephaly (HP:0000262) | 1.88182729 |
| 124 | Biconcave vertebral bodies (HP:0004586) | 1.87964969 |
| 125 | Aneurysm (HP:0002617) | 1.87887803 |
| 126 | Atrophic scars (HP:0001075) | 1.86939878 |
| 127 | Cerebral aneurysm (HP:0004944) | 1.85240908 |
| 128 | Hyperglycinuria (HP:0003108) | 1.84998563 |
| 129 | Annular pancreas (HP:0001734) | 1.84051189 |
| 130 | Neuronal loss in central nervous system (HP:0002529) | 1.83204770 |
| 131 | Entropion (HP:0000621) | 1.82590921 |
| 132 | Abnormality of complement system (HP:0005339) | 1.81326954 |
| 133 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.80931554 |
| 134 | Vertebral compression fractures (HP:0002953) | 1.80205214 |
| 135 | Stridor (HP:0010307) | 1.79667558 |
| 136 | Trismus (HP:0000211) | 1.79567608 |
| 137 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79429604 |
| 138 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79429604 |
| 139 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79429604 |
| 140 | Gingivitis (HP:0000230) | 1.79068947 |
| 141 | Amyloidosis (HP:0011034) | 1.78871480 |
| 142 | Recurrent abscess formation (HP:0002722) | 1.78867871 |
| 143 | Polygenic inheritance (HP:0010982) | 1.78820152 |
| 144 | Abnormality of the nasal mucosa (HP:0000433) | 1.76391990 |
| 145 | Progressive neurologic deterioration (HP:0002344) | 1.75609497 |
| 146 | Slender build (HP:0001533) | 1.75223923 |
| 147 | Muscle fiber splitting (HP:0003555) | 1.74306056 |
| 148 | Limb-girdle muscle atrophy (HP:0003797) | 1.73625033 |
| 149 | Hyperextensible skin (HP:0000974) | 1.73144370 |
| 150 | Hyperparathyroidism (HP:0000843) | 1.71959405 |
| 151 | Hypertriglyceridemia (HP:0002155) | 1.71403044 |
| 152 | Heart block (HP:0012722) | 1.70946526 |
| 153 | Abnormality of the Achilles tendon (HP:0005109) | 1.70570363 |
| 154 | Ragged-red muscle fibers (HP:0003200) | 1.70273704 |
| 155 | Abnormal atrioventricular conduction (HP:0005150) | 1.70063409 |
| 156 | Insomnia (HP:0100785) | 1.69784143 |
| 157 | Mitral stenosis (HP:0001718) | 1.69717134 |
| 158 | Growth hormone excess (HP:0000845) | 1.69511124 |
| 159 | Brushfield spots (HP:0001088) | 1.69393291 |
| 160 | Loss of speech (HP:0002371) | 1.69317567 |
| 161 | Torticollis (HP:0000473) | 1.68049799 |
| 162 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.67918758 |
| 163 | Fatigue (HP:0012378) | 1.67639117 |
| 164 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.67260272 |
| 165 | Hypercalcemia (HP:0003072) | 1.66856746 |
| 166 | Spinal cord lesions (HP:0100561) | 1.66658695 |
| 167 | Syringomyelia (HP:0003396) | 1.66658695 |
| 168 | Premature skin wrinkling (HP:0100678) | 1.65157387 |
| 169 | Arterial tortuosity (HP:0005116) | 1.63336747 |
| 170 | Abnormality of the thoracic spine (HP:0100711) | 1.62847415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.34364255 |
| 2 | ARAF | 3.70642473 |
| 3 | EPHA2 | 3.37789679 |
| 4 | MAP3K9 | 3.32818051 |
| 5 | TRIB3 | 3.09842844 |
| 6 | KSR2 | 2.93341811 |
| 7 | TESK2 | 2.89013642 |
| 8 | SIK1 | 2.74931093 |
| 9 | PRPF4B | 2.72104999 |
| 10 | SMG1 | 2.46681458 |
| 11 | ERN1 | 2.15255735 |
| 12 | KDR | 2.14223546 |
| 13 | MAP3K11 | 2.09979170 |
| 14 | TSSK6 | 2.07626237 |
| 15 | NME2 | 2.05872618 |
| 16 | RIPK1 | 2.02977277 |
| 17 | CAMKK2 | 1.93751558 |
| 18 | SCYL2 | 1.93099316 |
| 19 | ICK | 1.81753112 |
| 20 | NTRK1 | 1.78163228 |
| 21 | TAOK1 | 1.72153757 |
| 22 | TESK1 | 1.70403845 |
| 23 | PIM2 | 1.68357120 |
| 24 | ZAP70 | 1.60558904 |
| 25 | WEE1 | 1.56116200 |
| 26 | MARK2 | 1.50688201 |
| 27 | MAP3K2 | 1.50457960 |
| 28 | PRKD2 | 1.49831999 |
| 29 | CAMKK1 | 1.47605241 |
| 30 | MAP2K2 | 1.46593312 |
| 31 | BRAF | 1.46492259 |
| 32 | LIMK1 | 1.34157221 |
| 33 | PAK6 | 1.32972014 |
| 34 | MAP3K12 | 1.32614889 |
| 35 | MINK1 | 1.32456782 |
| 36 | NEK1 | 1.31468980 |
| 37 | LATS2 | 1.31082622 |
| 38 | NME1 | 1.29691869 |
| 39 | TTN | 1.27581445 |
| 40 | IRAK3 | 1.26721363 |
| 41 | MAP4K1 | 1.26431862 |
| 42 | RAF1 | 1.24121691 |
| 43 | BRSK1 | 1.23533924 |
| 44 | EIF2AK1 | 1.21680326 |
| 45 | PKN2 | 1.21441969 |
| 46 | EPHB1 | 1.15847110 |
| 47 | RPS6KA2 | 1.13899876 |
| 48 | STK16 | 1.13665620 |
| 49 | AKT3 | 1.11500868 |
| 50 | MAP3K1 | 1.07994201 |
| 51 | TYK2 | 1.07563684 |
| 52 | NTRK3 | 1.04641535 |
| 53 | EEF2K | 1.03570874 |
| 54 | PDGFRA | 1.02691165 |
| 55 | MAP2K1 | 1.02608361 |
| 56 | ALK | 1.01047820 |
| 57 | TBK1 | 1.00432666 |
| 58 | PRKCI | 1.00040830 |
| 59 | DYRK1B | 0.98377373 |
| 60 | FES | 0.97129994 |
| 61 | PTK2 | 0.94723792 |
| 62 | LRRK2 | 0.90931495 |
| 63 | PAK4 | 0.90792836 |
| 64 | BCKDK | 0.90326429 |
| 65 | MAP3K8 | 0.88343184 |
| 66 | BRSK2 | 0.87980034 |
| 67 | RIPK4 | 0.87021996 |
| 68 | TNK2 | 0.86175190 |
| 69 | BMX | 0.84520961 |
| 70 | CDC42BPA | 0.84126410 |
| 71 | DAPK1 | 0.84042113 |
| 72 | PDPK1 | 0.83299370 |
| 73 | MAP3K13 | 0.82668974 |
| 74 | RPS6KA4 | 0.81426757 |
| 75 | FGFR4 | 0.81165225 |
| 76 | RPS6KC1 | 0.79961778 |
| 77 | RPS6KL1 | 0.79961778 |
| 78 | PRKD3 | 0.79528969 |
| 79 | DDR2 | 0.79498413 |
| 80 | MAP3K6 | 0.77523547 |
| 81 | MAPKAPK3 | 0.77466254 |
| 82 | ABL2 | 0.76770995 |
| 83 | IRAK4 | 0.76292872 |
| 84 | RET | 0.76190912 |
| 85 | GRK6 | 0.76016847 |
| 86 | DAPK2 | 0.75708732 |
| 87 | EPHB2 | 0.74883783 |
| 88 | IRAK2 | 0.73933757 |
| 89 | PAK1 | 0.73739193 |
| 90 | NEK2 | 0.72867458 |
| 91 | CSK | 0.72587190 |
| 92 | MAPK12 | 0.71651637 |
| 93 | PAK3 | 0.71508758 |
| 94 | LMTK2 | 0.69020251 |
| 95 | CDK14 | 0.68904222 |
| 96 | GRK5 | 0.68139538 |
| 97 | TYRO3 | 0.67431807 |
| 98 | AURKA | 0.66335154 |
| 99 | PDK3 | 0.65035878 |
| 100 | PDK4 | 0.65035878 |
| 101 | MTOR | 0.64181514 |
| 102 | DAPK3 | 0.64048726 |
| 103 | PDK1 | 0.63347457 |
| 104 | MAP3K3 | 0.63211610 |
| 105 | KSR1 | 0.63018284 |
| 106 | CDK19 | 0.61495693 |
| 107 | HIPK2 | 0.60878584 |
| 108 | EIF2AK3 | 0.59100702 |
| 109 | RPS6KA6 | 0.56900674 |
| 110 | TGFBR2 | 0.56742940 |
| 111 | MYLK | 0.55944319 |
| 112 | PNCK | 0.54807785 |
| 113 | PINK1 | 0.54409873 |
| 114 | MAP3K5 | 0.53881301 |
| 115 | DMPK | 0.52794021 |
| 116 | FER | 0.52202138 |
| 117 | MOS | 0.50866504 |
| 118 | PRKCG | 0.50009358 |
| 119 | MARK1 | 0.48604361 |
| 120 | PRKD1 | 0.48447213 |
| 121 | CDK15 | 0.47621255 |
| 122 | CDK11A | 0.46320240 |
| 123 | MAP2K3 | 0.46113383 |
| 124 | CDK18 | 0.45843587 |
| 125 | PDK2 | 0.42973057 |
| 126 | CAMK1 | 0.42899229 |
| 127 | HCK | 0.42519677 |
| 128 | CDK12 | 0.41349084 |
| 129 | CAMK2G | 0.41164414 |
| 130 | ILK | 0.41131996 |
| 131 | MAPK4 | 0.40459379 |
| 132 | STK38 | 0.39658816 |
| 133 | PAK2 | 0.39473236 |
| 134 | FYN | 0.38782152 |
| 135 | PRKCH | 0.38369797 |
| 136 | SIK2 | 0.36944072 |
| 137 | UHMK1 | 0.36201358 |
| 138 | MAP3K7 | 0.35598020 |
| 139 | CDK5 | 0.35201137 |
| 140 | PRKG2 | 0.35179853 |
| 141 | TAOK2 | 0.34689146 |
| 142 | MAPK11 | 0.34451081 |
| 143 | CSNK1G2 | 0.33807832 |
| 144 | BTK | 0.33658423 |
| 145 | CSNK1G3 | 0.32393859 |
| 146 | CCNB1 | 0.30628699 |
| 147 | PTK6 | 0.28998148 |
| 148 | MARK3 | 0.28491859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.13096222 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.65223910 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.25387759 |
| 4 | Regulation of autophagy_Homo sapiens_hsa04140 | 3.13353587 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 3.00159013 |
| 6 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.29838190 |
| 7 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.24022565 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.21652318 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.15789689 |
| 10 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.12270336 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.99217354 |
| 12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.98233134 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.86198567 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.76849332 |
| 15 | RNA polymerase_Homo sapiens_hsa03020 | 1.71800114 |
| 16 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.69441673 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.67344635 |
| 18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.64530977 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52841558 |
| 20 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.49057261 |
| 21 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.46512669 |
| 22 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.46280299 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.44246848 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.43402151 |
| 25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.38526926 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.32049051 |
| 27 | Endocytosis_Homo sapiens_hsa04144 | 1.29643228 |
| 28 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.28081052 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.26301922 |
| 30 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.23472781 |
| 31 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.23130330 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.21831825 |
| 33 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.21595109 |
| 34 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.21224723 |
| 35 | Long-term potentiation_Homo sapiens_hsa04720 | 1.20997899 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13389977 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.12055828 |
| 38 | RNA transport_Homo sapiens_hsa03013 | 1.11644196 |
| 39 | Insulin secretion_Homo sapiens_hsa04911 | 1.11307729 |
| 40 | Galactose metabolism_Homo sapiens_hsa00052 | 1.10694726 |
| 41 | Amoebiasis_Homo sapiens_hsa05146 | 1.10132431 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.08879105 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07715229 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06354698 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05993799 |
| 46 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.03429033 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03345453 |
| 48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02114082 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99814417 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99110358 |
| 51 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.98607090 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98196326 |
| 53 | Focal adhesion_Homo sapiens_hsa04510 | 0.98124436 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97868884 |
| 55 | Malaria_Homo sapiens_hsa05144 | 0.96336779 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95815677 |
| 57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.94599798 |
| 58 | Endometrial cancer_Homo sapiens_hsa05213 | 0.93091852 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89278440 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.88487532 |
| 61 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.87713451 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86709965 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.84666666 |
| 64 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.84129502 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.83955832 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83945203 |
| 67 | Leishmaniasis_Homo sapiens_hsa05140 | 0.82149036 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81933509 |
| 69 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.81493331 |
| 70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.80931431 |
| 71 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80930258 |
| 72 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.79527886 |
| 73 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.79313770 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78994612 |
| 75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.78487055 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77974385 |
| 77 | Gap junction_Homo sapiens_hsa04540 | 0.77064933 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.76921516 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.73959247 |
| 80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73928545 |
| 81 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73676247 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72936529 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72769309 |
| 84 | GABAergic synapse_Homo sapiens_hsa04727 | 0.72489084 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72413815 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71871249 |
| 87 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71572206 |
| 88 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.71560128 |
| 89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70067816 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69698626 |
| 91 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.69173199 |
| 92 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.68936703 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68046636 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.67765119 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67468382 |
| 96 | Bile secretion_Homo sapiens_hsa04976 | 0.67209834 |
| 97 | Melanogenesis_Homo sapiens_hsa04916 | 0.66757526 |
| 98 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65879218 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65191691 |
| 100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65124011 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.64243788 |
| 102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63411281 |
| 103 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63285157 |
| 104 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.61145464 |
| 105 | Platelet activation_Homo sapiens_hsa04611 | 0.60779721 |
| 106 | Purine metabolism_Homo sapiens_hsa00230 | 0.60347975 |
| 107 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.60233758 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.59393559 |
| 109 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59313128 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | 0.58290994 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57960657 |
| 112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57833444 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.57675374 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.57012120 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.56924002 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56846117 |
| 117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56591051 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55858612 |
| 119 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54400660 |
| 120 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54047073 |
| 121 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.53778240 |
| 122 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53603123 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52726638 |
| 124 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51922571 |
| 125 | Salivary secretion_Homo sapiens_hsa04970 | 0.51154285 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50306881 |
| 127 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50296437 |
| 128 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.48284355 |
| 129 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.48283363 |
| 130 | Circadian entrainment_Homo sapiens_hsa04713 | 0.48236408 |
| 131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47780076 |
| 132 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47668903 |
| 133 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47418513 |
| 134 | Glioma_Homo sapiens_hsa05214 | 0.44573057 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43832353 |
| 136 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.43535941 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.42744900 |
| 138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41836966 |
| 139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41462605 |
| 140 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.40763080 |
| 141 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40339209 |
| 142 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39964602 |
| 143 | Ribosome_Homo sapiens_hsa03010 | 0.38077451 |
| 144 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37565107 |
| 145 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37484973 |
| 146 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.37330465 |
| 147 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36560595 |
| 148 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36446395 |
| 149 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35752778 |
| 150 | Cocaine addiction_Homo sapiens_hsa05030 | 0.35260522 |
| 151 | Olfactory transduction_Homo sapiens_hsa04740 | 0.35072918 |
| 152 | Phagosome_Homo sapiens_hsa04145 | 0.34517895 |

